The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
Open accessAbstract
Dengue viruses (DENV) are the etiological agents of dengue fever (DF) and dengue hemorrhagic fever (DHF). The DENV complex consists of four closely related viruses designated DENV serotypes 1 through-4. Although infection with one serotype induces cross reactive antibody to all 4 serotypes, the long term protective antibody response is restricted to the serotype responsible for infection. Cross-reactive antibodies appear to enhance infection during a second infection with a different serotype. The goal of the present study was to characterize the binding specificity and functional properties of human DENV immune sera. The study focused on domain III of the viral envelope protein (EDIII), as this region has a well characterized epitope that is recognized by strongly neutralizing serotype-specific mouse monoclonal antibodies (Mabs). Our results demonstrate that EDIII-reactive antibodies are present in primary and secondary DENV immune human sera. Human antibodies bound to a serotype specific epitope on EDIII after primary infection and a serotype cross reactive epitope on EDIII after secondary infection. However, EDIII-binding antibodies constituted only a small fraction of the total antibody in immune sera binding to DENV. Studies with complete and EDIII antibody depleted human immune sera demonstrated that EDIII binding antibodies play a minor role in DENV neutralization. We propose that human antibodies directed to other epitopes on the virus are primarily responsible for DENV neutralization. Our results have implications for understanding protective immunity following natural DENV infection and for evaluating DENV vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution
Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C., & Harrison, S. C. (1995) · Nature · doi:10.1038/375291a0 · Cited by 1,437
A ligand-binding pocket in the dengue virus envelope glycoprotein
Modis, Y., Ogata, S., Clements, D., & Harrison, S. C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832193100 · Cited by 1,061
Neutralization and Antibody-Dependent Enhancement of Dengue Viruses
Halstead, S. B. (2003) · Advances in Virus Research · doi:10.1016/s0065-3527(03)60011-4 · Cited by 739
Variable Surface Epitopes in the Crystal Structure of Dengue Virus Type 3 Envelope Glycoprotein
Modis, Y., Ogata, S., Clements, D., & Harrison, S. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1223-1231.2005 · Cited by 429
Dengue: defining protective versus pathologic immunity
Rothman, A. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421512 · Cited by 364
Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins
Lok, S.-M., Kostyuchenko, V., Nybakken, G. E., Holdaway, H. A., Battisti, A. J., Sukupolvi-Petty, S., Sedlak, D., Fremont, D. H., Chipman, P. R., Roehrig, J. T., et al. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1382 · Cited by 354
Structural basis of West Nile virus neutralization by a therapeutic antibody
Nybakken, G. E., Oliphant, T., Johnson, S., Burke, S., Diamond, M. S., & Fremont, D. H. (2005) · Nature · doi:10.1038/nature03956 · Cited by 352
Lai, C.-Y., Tsai, W.-Y., Lin, S.-R., Kao, C.-L., Hu, H.-P., King, C.-C., Wu, H.-C., Chang, G.-J., & Wang, W.-K. (2008) · Journal of Virology · doi:10.1128/jvi.00316-08 · Cited by 326
Monoclonal Antibody Mapping of the Envelope Glycoprotein of the Dengue 2 Virus, Jamaica
Roehrig, J. T., Bolin, R. A., & Kelly, R. G. (1998) · Virology · doi:10.1006/viro.1998.9200 · Cited by 307
Antigenic Structure of Flavivirus Proteins
Roehrig, J. T. (2003) · Advances in Virus Research · doi:10.1016/s0065-3527(03)59005-4 · Cited by 279
Crystal Structure of the West Nile Virus Envelope Glycoprotein
Nybakken, G. E., Nelson, C. A., Chen, B. R., Diamond, M. S., & Fremont, D. H. (2006) · Journal of Virology · doi:10.1128/jvi.01125-06 · Cited by 264
Sukupolvi-Petty, S., Austin, S. K., Purtha, W. E., Oliphant, T., Nybakken, G. E., Schlesinger, J. J., Roehrig, J. T., Gromowski, G. D., Barrett, A. D., Fremont, D. H., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00432-07 · Cited by 263
Henchal, E. A., Burke, D. S., Brandt, W. E., McCown, J. M., & Seguin, M. C. (1985) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1985.34.162 · Cited by 199
Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus
Oliphant, T., Nybakken, G. E., Austin, S. K., Xu, Q., Bramson, J., Loeb, M., Throsby, M., Fremont, D. H., Pierson, T. C., & Diamond, M. S. (2007) · Journal of Virology · doi:10.1128/jvi.00643-07 · Cited by 171
Gromowski, G. D., Barrett, N. D., & Barrett, A. D. T. (2008) · Journal of Virology · doi:10.1128/jvi.00606-08 · Cited by 170
Comparison of Plaque- and Flow Cytometry-Based Methods for Measuring Dengue Virus Neutralization
Kraus, A., Messer, W. B., Haymore, L. B., & de Silva, A. M. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00827-07 · Cited by 148
Self-citationHalstead, S. B. (2002) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200210000-00003 · Cited by 118
Volk, D. E., Beasley, D. W. C., Kallick, D. A., Holbrook, M. R., Barrett, A. D. T., & Gorenstein, D. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402385200 · Cited by 113
Dengue Vaccines Approach the Finish Line
Edelman, R. (2007) · Clinical Infectious Diseases · doi:10.1086/518148 · Cited by 98
Solution structure of the envelope protein domain III of dengue-4 virus
Volk, D. E., Lee, Y.-C., Li, X., Thiviyanathan, V., Gromowski, G. D., Li, L., Lamb, A. R., Beasley, D. W. C., Barrett, A. D. T., & Gorenstein, D. G. (2007) · Virology · doi:10.1016/j.virol.2007.02.023 · Cited by 67
Yu, S., Wuu, A., Basu, R., Holbrook, M. R., Barrett, A. D. T., & Lee, J. C. (2004) · Biochemistry · doi:10.1021/bi049324g · Cited by 42
Goncalvez, A. P., Men, R., Wernly, C., Purcell, R. H., & Lai, C. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.12910-12918.2004 · Cited by 42
The neutralizing antibody response against West Nile virus in naturally infected horses
Sánchez, M. D., Pierson, T. C., DeGrace, M. M., Mattei, L. M., Hanna, S. L., Piero, F. D., & Doms, R. W. (2006) · Virology · doi:10.1016/j.virol.2006.08.047 · Cited by 39
Maillard, R. A., Jordan, M., Beasley, D. W. C., Barrett, A. D. T., & Lee, J. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706031200 · Cited by 16
Cited by
Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms
Rothman, A. L. (2011) · Nature Reviews Immunology · doi:10.1038/nri3014 · Cited by 770
Beltramello, M., Williams, K. L., Simmons, C. P., Macagno, A., Simonelli, L., Quyen, N. T. H., Sukupolvi-Petty, S., Navarro-Sanchez, E., Young, P. R., de Silva, A. M., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.08.007 · Cited by 592
Self-citationIdentification of human neutralizing antibodies that bind to complex epitopes on dengue virions
de Alwis, R., Smith, S. A., Olivarez, N. P., Messer, W. B., Huynh, J. P., Wahala, W. M. P. B., White, L. J., Diamond, M. S., Baric, R. S., Crowe, J. E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200566109 · Cited by 390
Self-citationThe Human Antibody Response to Dengue Virus Infection
Wahala, W. M. P. B., & De Silva, A. M. (2011) · Viruses · doi:10.3390/v3122374 · Cited by 354
Self-citationDengue Antibody-Dependent Enhancement: Knowns and Unknowns
Halstead, S. B. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.aid-0022-2014 · Cited by 336
Metadata
- Authors
- Wahala, W. M. P. B., Kraus, A. A., Haymore, L. B., Accavitti-Loper, M. A., & de Silva, A. M.
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 392
- Issue
- 1
- Pages
- 103-113
- ISSN
- 0042-6822 (ISSN-L)
- OpenAlex
- W1986082370
- Cited by
- 274
- References
- 24
- FWCI
- 17.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.